Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen

Digestive and Liver Disease

Volumn 41, Issue 4, 2009, Pages 269-276

  Latella, G ^a   Cocco, A ^b   Angelucci, E ^b   Viscido, A ^b   Bacci, S ^b   Necozione, S ^a   Caprilli, R ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Clinical course; Crohn's disease; Immunosuppressants; Post operative recurrence; Steroids

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; PREDNISONE; STEROID;

ABDOMINAL SURGERY; ACUTE ABDOMEN; ADOLESCENT; ADULT; AGED; APPENDECTOMY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CROHN DISEASE; DISEASE COURSE; EARLY INTERVENTION; ENTERITIS; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

ABDOMEN, ACUTE; ADOLESCENT; ADULT; AGED; COMORBIDITY; CROHN DISEASE; DISEASE PROGRESSION; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 62049083065     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.09.010     Document Type: Article

References (59)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
2. Whelan G. Epidemiology of inflammatory bowel disease. Med Clin North Am 7 (1990) 1-12
3. Loftus E.V., Silverstein M.D., Sandborn W.J., Tremaine W.J., Harmsen W.S., and Zinsmeister A.R. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 114 (1998) 1161-1168
4. Loftus E.V., Schoenfeld P., and Sandborn W.J. The epidemiology and natural history of Crohn's disease in a population-based patient cohort from North America: a systematic review. Aliment Pharmacol Ther 16 (2002) 51-60
5. Silverstein M.D., Loftus E.V., Sandborn W.J., Tremain W.J., Feagan B.G., Nietert P.J., et al. Clinical course and costs of care for Crohn's disease: a Markov model analysis of a population-based cohort. Gastroenterology 117 (1999) 49-57
6. Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics 20 (2002) 639-652
7. Odes S., Vardi H., Friger M., Wolters F., Russel M.G., Riis L., et al. European Collaborative Study on Inflammatory Bowel Disease. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 131 (2006) 719-728
8. Gasche C., Schoelmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., et al. A simple classification of Crohn's disease: report of the working party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6 (2000) 8-15
9. Hinojosa J., Nos P., Ramirez J.J., Hoyos M., Moles J.R., Ponce J., et al. Evolutive pattern of Crohn's disease: a simplified index using clinical parameters predicts obstructive behaviour. Eur J Gastroenterol Hepatol 13 (2001) 245-249
10. Luis E., Collard A., Oger A.F., Degroote E., Aboul Nasr El Yafi F., and Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49 (2001) 777-782
11. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonel F., Park R., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 8 (2002) 244-250
12. Papi C., Festa V., Fagnani C., Stazi A., Antonelli G., Moretti M., et al. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Digest Liver Dis 37 (2005) 247-253
13. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal Word Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
14. Satsangi J., Silverberg M.S., Vermeire S., and Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implication. Gut 55 (2006) 749-753
15. Munkholm P., Langholz E., Davidsen M., and Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 30 (1995) 699-706
16. Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl 490 (1979) 1-84
17. Witte J., Shivananda S., Lennard-Jones J.E., Beltrami M., Politi P., Bonanomi A., et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 35 (2000) 1272-1277
18. Bernell O., Lapidus A., and Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 87 (2000) 1697-1701
19. Penner R.M., Madsen K.L., and Fedorak R.N. Postoperative Crohn's disease. Inflamm Bowel Dis 11 (2005) 765-777
20. Caprilli R., Gassull M.A., Escher J.C., Moser G., Munkholm P., Forbes A., et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 55 Suppl 1 (2006) i36-i58
21. Travis S.P., Stange E.F., Lemann M., Oresland T., Chowers Y., Forbes A., et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 55 Suppl 1 (2006) i16-i35
22. Rutgeerts P., Geboes K., Vantrappen G., Kerremans R., Coenegrachts J.L., and Coremans G. Natural history of recurrent Crohn's disease at the ileo-colonic anastomosis after curative surgery. Gut 25 (1984) 665-672
23. Caprilli R., Corrao G., Taddei G., Tonelli F., Torchio P., and Viscido A. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum 39 (1996) 335-341
24. Wolff B.G. Factors determining recurrence following surgery for Crohn's disease. World J Surg 22 (1998) 364-369
25. Softley A., Myren J., Clamp S.E., Bouchier I.A., Watkinson G., and de Dombal F.T. Factors affecting recurrence after surgery for Crohn's disease. Scand J Gastroenterol Suppl 144 (1988) 31-34
26. Borley N.R., Mortensen N.J.M., Chaundry M.A., Mohammed S., Warren B.F., George B.D., et al. Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure. Dis Colon Rectum 45 (2002) 377-383
27. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 11 (2005) 3971-3979
28. Hellers G., Cortot A., Jewell D., Leijonmarck C.E., Lofberg R., Malchow H., et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 116 (1999) 294-300
29. Caprilli R., Cottone M., Tonelli F., Sturniolo G., Castiglione F., Annese V., et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 17 (2003) 517-523
30. Hanauer S.B., Korelitz B.I., Rutgeerts P., Peppercorn M.A., Thisted R.A., Cohen R.D., et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 127 (2004) 723-729
31. Rutgeerts P., Van Assche G., Vermeire S., D'Haens G., Baert F., Noman M., et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128 (2005) 856-861
32. Rutgeerts P. Strategies in the prevention of post-operative recurrence in Crohn's disease. Best Pract Res Clin Gastroenterol 17 (2003) 63-73
33. Cottone M., Orlando A., and Modesto I. Postoperative maintenance therapy for inflammatory bowel disease. Curr Opin Gastroenterol 22 (2006) 377-381
34. Markowitz J., Markowitz J.E., Bousvaros A., Crandall W., Faubion W., Kirschner B.S., et al. Workshop report: prevention of postoperative Crohn's disease. J Pediatr Gastroenterol Nutr 41 (2005) 145-151
35. Michelassi F., Balestracci T., Chappell R., and Block G.E. Primary and recurrent Crohn's disease. Ann Surg 214 (1991) 230-239
36. Krupnick A.S., and Morris J.B. The long-term results of resection and multiple resections in Crohn's disease. Semin Gastrointest Dis 11 (2000) 41-51
37. Siassi M., Weiger A., Hohenberger W., and Kessler H. Change in surgical therapy for Crohn's disease over 33 years: a prospective longitudinal study. Int J Colorectal Dis 22 (2007) 319-324
38. Poggioli G., Pierangeli F., Laureti S., and Ugolini F. Review article: indication and type of surgery in Crohn's disease. Aliment Pharmacol Ther 16 Suppl 4 (2002) 59-64
39. Sands B.E., Arsenault J.E., Rosen M.J., Alsahli M., Bailen L., Banks P., et al. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol 98 (2003) 2712-2718
40. Cosnes J., Nion-Larmurier I., Beaugerie L., Afchain P., Tiret E., and Gendre J.P. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54 (2005) 237-241
41. Rutgeerts P. Review article: recurrence of Crohn's disease after surgery-the need for treatment of new lesions. Aliment Pharmacol Ther 24 Suppl 3 (2006) 29-32
42. Chang J.T., and Lichtenstein G.R. Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 220-228
43. Siegel C.A., Hur C., Korzenik J.R., Gazelle G.S., and Sands B.E. Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol 4 (2006) 1017-1024
44. Hulten L. Surgical management and strategy in classical Crohn's disease. Int Surg 77 (1992) 2-8
45. Kim N.K., Senagore A.J., Luchtefeld M.A., MacKeigan J.M., Mazier W.P., Belknap K., et al. Long-term outcome after ileocecal resection for Crohn's disease. Am Surg 63 (1997) 627-633
46. Delaney C.P., and Fazio V.W. Crohn's disease of the small bowel. Surg Clin North Am 81 (2001) 137-158
47. Kelly J.K., and Preshaw R.M. Origin of fistulas in Crohn's disease. J Clin Gastroenterol 11 (1989) 193-196
48. Present D.H. Crohn's fistula: current concepts in management. Gastroenterology 124 (2003) 1629-1635
49. Schwartz D.A., Loftus Jr. E.V., Tremaine W.J., Panaccione R., Harmsen W.S., Zinsmeister A.R., et al. The natural history of fistulizing Crohn's disease in Olmsted County Minnesota. Gastroenterology 122 (2002) 875-880
50. Lichtenstein G.R. Treatment of fistulizing Crohn's disease. Gastroenterology 119 (2000) 1132-1147
51. Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., and Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease. A population-based study. Gastroenterology 121 (2001) 255-260
52. Vader J.P., Froehlich F., Juillerat P., Burnand B., Felley C., Gonvers J.J., et al. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach-EPACT. Digestion 73 (2006) 237-248
53. Hanauer S.B., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359 (2002) 1541-1549
54. Lichtenstein G.R., Yan S., Bala M., Blank M., and Sands B.E. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 128 (2005) 862-869
55. Vermeire S., Van Assche G., and Rutgeerts P. Review article: altering the natural history of Crohn's disease-evidence for and against current therapies. Aliment Pharmacol Ther 25 (2007) 3-12
56. Van Assche G., Geboes K., and Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis 10 (2004) 55-60
57. Aratari A., Papi C., Leandro G., Viscido A., Capurso L., and Caprilli R. Early versus late surgery for ileo-caecal Crohn's disease. Aliment Pharmacol Ther 26 (2007) 1303-1312
58. Cullen G., O'Toole A., Keegan D., Sheahan K., Hyland J.M., and O'Donoghue D.P. Long-term clinical results of ileocecal resection for Crohn's disease. Inflamm Bowel Dis 13 (2007) 1369-1373
59. Kim N.K., Senagore A.J., Luchtefeld M.A., MacKeigan J.M., Belknap K., and Chen S.H. Long-term outcome after ileocecal resection for Crohn's disease. Am Surg 63 (1997) 627-633